<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients With Refractory Metastatic Soft-Tissue Sarcoma</article-title>. 
  <source>Clin Cancer Res</source> (
  <year>2018</year>) 
  <volume>24</volume>(
  <issue>21</issue>):
  <page-range>5233â€“8</page-range>. 
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-17-3766</pub-id>
 </mixed-citation>
</ref>
